Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALPN

Alpine Immune Sciences (ALPN) Stock Price, News & Analysis

Alpine Immune Sciences logo

About Alpine Immune Sciences Stock (NASDAQ:ALPN)

Advanced Chart

Key Stats

Today's Range
$64.97
$64.97
50-Day Range
$64.37
$64.97
52-Week Range
$8.33
$65.00
Volume
2 shs
Average Volume
1.92 million shs
Market Capitalization
$4.46 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALPN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpine Immune Sciences and its competitors with MarketBeat's FREE daily newsletter.

ALPN Stock News Headlines

Alpine Immune Sciences Inc.
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
What 11 Analyst Ratings Have To Say About Alpine Immune Sciences
Alpine Immune Sciences Inc
See More Headlines

ALPN Stock Analysis - Frequently Asked Questions

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) released its earnings results on Tuesday, November, 9th. The biotechnology company reported ($0.55) EPS for the quarter, missing analysts' consensus estimates of $0.01 by $0.56. The biotechnology company earned $8.52 million during the quarter, compared to the consensus estimate of $22.30 million. Alpine Immune Sciences had a negative net margin of 65.17% and a negative trailing twelve-month return on equity of 14.86%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alpine Immune Sciences investors own include NVIDIA (NVDA), Broadcom (AVGO), e.l.f. Beauty (ELF), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL) and Novo Nordisk A/S (NVO).

Company Calendar

Last Earnings
11/09/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ALPN
CIK
1626199
Employees
142
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.18 million
Net Margins
-65.17%
Pretax Margin
-64.99%
Return on Equity
-14.86%
Return on Assets
-11.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.56
Quick Ratio
9.56

Sales & Book Value

Annual Sales
$56.52 million
Price / Sales
78.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.85 per share
Price / Book
13.40

Miscellaneous

Outstanding Shares
68,598,000
Free Float
39,581,000
Market Cap
$4.46 billion
Optionable
Optionable
Beta
0.97
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ALPN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners